Michael Mason Karyopharm Therapeutics Inc. (KPTI) insider trading activity

KPTI Quotes by TradingView

Michael Mason is EVP, CFO & Treasurer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 391,054 shares of KPTI, which is worth approximately $305,022. The most recent transaction as insider was on Sep 04, 2024, when has been sold 7,050 shares (Common Stock) at a price of $0.72 per share, resulting in proceeds of $5,076. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 391K
1.77% 3M change
64.43% 12M change
Total Value Held $305,022

Michael Mason Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 04 2024
SELL
Open market or private sale
$5,076 $0.72 p/Share
7,050 Reduced 1.77%
391,054 Common Stock
Jun 04 2024
SELL
Open market or private sale
$645 $0.99 p/Share
652 Reduced 0.16%
398,104 Common Stock
Mar 01 2024
SELL
Open market or private sale
$7,394 $1.2 p/Share
6,162 Reduced 1.52%
398,756 Common
Feb 29 2024
SELL
Open market or private sale
$32,393 $1.17 p/Share
27,687 Reduced 6.4%
404,918 Common
Feb 28 2024
BUY
Grant, award, or other acquisition
-
188,205 Added 30.32%
432,605 Common Stock
Feb 27 2024
SELL
Open market or private sale
$3,359 $1.32 p/Share
2,545 Reduced 1.03%
244,400 Common Stock
Feb 06 2024
SELL
Open market or private sale
$6,685 $1.59 p/Share
4,205 Reduced 1.67%
246,945 Common Stock
Jan 24 2024
BUY
Grant, award, or other acquisition
-
13,333 Added 5.04%
251,150 Common Stock
Sep 01 2023
SELL
Open market or private sale
$9,194 $1.33 p/Share
6,913 Reduced 2.82%
237,817 Common Stock
Jun 02 2023
SELL
Open market or private sale
$1,400 $2.22 p/Share
631 Reduced 0.26%
244,730 Common Stock
Mar 01 2023
SELL
Open market or private sale
$33,951 $3.03 p/Share
11,205 Reduced 4.37%
245,361 Common Stock
Feb 28 2023
BUY
Grant, award, or other acquisition
-
95,000 Added 27.02%
256,566 Common Stock
Feb 27 2023
SELL
Open market or private sale
$8,518 $3.04 p/Share
2,802 Reduced 1.7%
161,566 Common Stock
Feb 06 2023
SELL
Open market or private sale
$14,079 $3.4 p/Share
4,141 Reduced 2.46%
164,368 Common Stock
Aug 31 2022
BUY
Grant, award, or other acquisition
-
30,000 Added 15.11%
168,509 Common Stock
Jun 03 2022
SELL
Open market or private sale
$3,642 $6.06 p/Share
601 Reduced 0.43%
138,509 Common Stock
Feb 28 2022
SELL
Open market or private sale
$24,556 $10.24 p/Share
2,398 Reduced 1.69%
139,110 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
88,200 Added 38.4%
141,508 Common Stock
Feb 07 2022
SELL
Open market or private sale
$38,917 $9.86 p/Share
3,947 Reduced 6.89%
53,308 Common Stock
Jun 01 2021
BUY
Grant, award, or other acquisition
-
5,500 Added 8.76%
57,255 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
22,013 Added 29.84%
51,755 Common Stock
Feb 11 2021
SELL
Open market or private sale
$44,356 $15.52 p/Share
2,858 Reduced 35.07%
5,292 Common Stock
Feb 05 2021
BUY
Exercise of conversion of derivative security
-
8,150 Added 50.0%
8,150 Common Stock
MM

Michael Mason

EVP, CFO & Treasurer
Newton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KPTI